ACE Pharmaceuticals is member of the ACE-group, together with ARTECEF (medicines for tropical diseases) and Orphan Drugs NL (orphan drugs). All production activities are performed by ACE Pharmaceuticals under its manufacturer’s license and with full respect for GMP. Sister companies ARTECEF and Orphan Drugs NL take care of the distribution of their own specific medicines (in Europe). Since 2011 we supply our unlicensed medicines through ACE Apotheek (Pharmacy) in the Netherlands.
Board of Directors: J.W. Popma, J.A. Verwaal
Chamber of Commerce Registration 39061666 | VAT no. NL810171624.B02
Licenses ACE Pharmaceuticals
ACE focuses on two main activities: medical need products and clinical trial medication for (our own) studies.
ACE independently develops, manufactures, submits dossiers for registration and markets her branded products. Most activities are performed on our own premises.
In the Netherlands, our licensed medicines are distributed by the pharmaceuticals wholesalers to (hospital) pharmacies.
Our unlicensed medicines are supplied through ACE Apotheek, with respect for article 3.17 Regeling Geneesmiddelenwet (2007).
A physician’s statement is obligatory with every order.
We supply a limited number of products from our portfolio outside the Netherlands.
ACE is committed to making and keeping medical need products available and accessible. Sometimes, these medicines are indispensable for small patient groups or specific indications.
With our typical inventiveness we can also give existing medicines a second chance, sometimes with a new indication. “Orphaned” medicines can remain available for the patient this way as well.